GreenVision Acquisition Corp. (GRNV) Stock Analysis
NASDAQFinancial ServicesShell Companies
What GreenVision Acquisition Corp. does
GreenVision Acquisition Corp. is primarily focused on bringing about corporate combinations, utilizing methods such as mergers, stock exchanges, asset acquisitions, share purchases, or broader reorganizations with other entities. The company's strategic attention is directed towards businesses operating within the life sciences and healthcare sectors across North America, Europe, and Asia. Established in 2019, the firm's main office is located in New York, New York.
Key metrics
ETFs linked to GRNV
Broad-market and Financial Services sector ETFs an investor holding GreenVision Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how GRNV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze GRNV in PortView →Frequently asked questions
- What is the ticker symbol for GreenVision Acquisition Corp.?
- GreenVision Acquisition Corp. trades under the ticker GRNV on NASDAQ.
- Which exchange is GRNV listed on?
- GRNV is listed on NASDAQ.
- What sector does GreenVision Acquisition Corp. operate in?
- GreenVision Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).
- How can PortView help analyze GRNV in a portfolio?
- PortView shows GRNV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.